An FDA advisory panel is discussing today the safety -- and possible withdrawal from the market -- of three asthma drugs: Serevent, Advair, and Foradil. A recommendation by the expert panel is ...

Nov. 18, 2005 — The U.S. Food and Drug Administration (FDA) has warned healthcare professionals regarding the increased risk of severe asthma episodes and death associated with use of inhalation ...

On November 18, 2005, FDA alerted health care professionals and patients that several long-acting bronchodilator medicines have been associated with possible increased risk of worsening wheezing ...

The FDA has issued a public health advisory highlighting the correct use of Spiriva (tiotropium bromide inhalation powder, from Boehringer Ingelheim) and Foradil (formoterol fumarate inhalation powder ...

The FDA has ruled that two asthma medications, Serevent and Foradil, have risks that far outweigh their benefits for both children and adults. But don't take your child off the medication—speak to ...

ROCKVILLE, Md. — A panel of federal drug experts voted Thursday to recommend the drugs Serevent and Foradil be banned for the treatment of asthma, but the experts said Advair and Symbicort should ...

WASHINGTON — Two federal drug officials have concluded that asthma patients risk death if they continue to use four hugely popular asthma drugs: Advair, Symbicort, Serevent and Foradil. But the ...

Government health advisers Thursday called for restrictions on some long-acting asthma drugs, but spared Advair, a top-selling medication used by millions of patients. Outside experts advising the ...

The Food and Drug Administration (FDA) announced that Foradil Aerolizer (formoterol fumarate; Merck) has been discontinued. The decision to discontinue the product is business-related and not due to ...

WASHINGTON, March 3 (UPI) -- The U.S. Food and Drug Administration has issued a public health advisory concerning the correct use of Spiriva and Foradil capsules. The FDA said it learned many patients ...